default

Request a Quote

Public Health Alerts

  1. April 10, 2024

    Meningococcal Meningitis on the Rise

    The CDC is alerting doctors to be on the lookout for certain types of rare, serious meningococcal infections that are on the rise in the United States.

    This alarming increase is caused by Neisseria meningitidis bacteria, which has caused 1 in 6 people to die, a higher fatality rate than they typically see with meningococcal infections.

    These cases are also unusual because they are striking middle-aged adults. Typically, meningitis infections strike babies or adolescents and young adults.

    Read More
  2. April 03, 2024

    Turning the Tide: The NSCSS Task Force's Battle Against Rising Syphilis Rates

    The Centers for Disease Control and Prevention (CDC) recently released its 2022 Sexually Transmitted Infections (STI) Surveillance Report providing U.S. data for nationally notifiable STI’s for federally funded control programs.

    According to the report, syphilis cases (all stages and congenital syphilis) increased 80 percent from 2018-2022. More than 3,700 congenital syphilis cases were reported in 2022, reflecting an alarming 937 percent increase in the past decade, said Laura Bachmann, MD, MPH, Acting Director, CDC’s Division of STD Prevention in her announcement letter included in the report.

    Read More
  3. January 12, 2024

    Cases of Group A Streptococcus Continue to Climb

    We began to see an increase in the number of strep throat cases in beginning in late spring of 2023, not only in pediatric patients, but adults as well. Now in December, cases of Group A Streptococcus (GAS) continue to rise. During one newscast out of the Midwest, some physicians say 2023 was the worst year for strep throat that they can remember.
    Read More
  4. November 17, 2023

    Alarming increase in Cyclospora cases in the US

    A total of 1,957 laboratory-confirmed cases of cyclosporiasis have been reported in the United States so far this year.

    That is already surpassing the 1,129 cases reported in all of 2022. (1) The investigation of this outbreak is ongoing with no specific food item being identified as the source of most of these illnesses, although the outbreak count does include 20 patients in

    ...
    Read More
  5. September 13, 2023

    Leprosy - Old Disease Makes a Comeback in Florida

    In some cases in Florida, patients with leprosy report contact with armadillos, but others to not. These are the only animals known to harbor the disease and have been known to spit when people get too close.
    Read More
  6. September 08, 2023

    Will the New EG.5 Variant Cause a Pandemic Rerun?

    May 11th of 2023 marked the end of both the public health emergency and the national state of emergency for the COVID-19 pandemic. However, health professionals are concerned with the rise of the EG.5 variant, an up-and-coming SARS-CoV-2 strain that is potentially more transmissible than any of the current circulating strains in the United States. (1) EG.5 is a descendant of the Omicron lineage XBB.1.9.5

    ...
    Read More
  7. May 19, 2023

    Rising Incidence of XDR Shigella

    CDC issues an alert...Super Shigella on the Rise

    ...
    Read More
  8. April 19, 2023

    Cooling Towers That Spread Legionella Infections

    Rising Legionella Infections and Its Prevention in Industrial Cooling Towers

    Although Legionella is found naturally in freshwater environments, it becomes a health concern to the population w

    ...
    Read More
  9. January 20, 2023

    Acid Inhibitors Found to Stimulate C. diff Infections

    Clostridioides difficile (formerly named Clostridium difficile, and widely known as C. diff) is a Gram-positive, spore-forming, obligate anaerobe that causes life-threatening diarrhea in people who take antibiotics, are hospitalized or in nursing homes, and people with weakened immune systems.(1)

    ...
    Read More
  10. November 21, 2022

    Predictions for this Winter...A One-Two Punch?

    Two years ago, there was virtually no flu season due to COVID-19 isolation.

    In addition, experts predict another COVID-19 surge this fall and winter.(2) According to the World Health Organization’s early October global situation report, more than 1.5 million COVID-19 diagnosis were reported across Europe during the week ending Oct. 2, a

    ...
    Read More
  11. September 30, 2022

    Candida auris - A Deadly Form of Yeast

    Emerging hand in hand with the Pandemic...

    A new 2022 special report from the CDC is sounding the alarm that antimicrobial resistance to some of the most concerning bacteria and fungi significantly increased during the COVID-19 pandemic (1) One such highly drug resistant yeast noted in the report is Candida...

    Read More
  12. August 19, 2022

    A New and Better Way? Novavax COVID-19 Vaccine

    Effective vaccinations for COVID-19 have been readily available in the United States for well over a year and a new vaccine has just been added to the arsenal. Novavax (NVX-CoV2373), created by a company of the same name, was granted emergency use authorization in early July and has now been endorsed by the CDC.(2) Novavax is approved for adults who are 18 years and older and currently is limited to...

    Read More
  13. August 05, 2022

    The Rising Resistance of Group B Strep and Group A Strep

    Group A Streptococcus (GAS) is the most common bacterial cause of pharyngitis, often referred to as strep throat. GAS can also cause severe invasive infections. People who are elderly, have skin breakdown (when the skin is deprived of blood flow, the skin can become damaged or develop ulcers), or have chronic medical conditions, such as diabetes, are at increased risk. Each year in the United States...

    Read More
  14. July 22, 2022

    Human Metapneumovirus

    Another respiratory virus of concern. Common, yet underdiagnosed...

    Every year we anticipate the rounds of respiratory syncytial virus (RSV), influenza, and now Covid-19; but there is a lesser-known culprit of seasonal respiratory infections.

    ...

    Read More
  15. March 21, 2022

    New Drugs in the Fight Against COVID-19

    As the COVID-19 pandemic moves into its third year, new treatment options to combat the coronavirus disease are being authorized by the U.S. Food and Drug Administration. In December, 2021, the FDA issued emergency use authorization (EUA) for two oral antiviral treatments for COVID-19, Molnupiravir and Paxlovid.(1,2)
    This comes at a crucial time in the pandemic as new variants emerge and COVID-19...

    Read More
Page